z-logo
Premium
Confirming an expanded spectrum of SCN2A mutations: a case series
Author(s) -
Matalon Dena,
Goldberg Ethan,
Medne Livija,
Marsh Eric D.
Publication year - 2014
Publication title -
epileptic disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.673
H-Index - 53
eISSN - 1950-6945
pISSN - 1294-9361
DOI - 10.1684/epd.2014.0641
Subject(s) - dravet syndrome , epilepsy , channelopathy , mutation , sodium channel , scn3a , medicine , phenotype , epilepsy syndromes , genetics , g alpha subunit , gene , biology , protein subunit , sodium , chemistry , psychiatry , organic chemistry
Mutations in sodium channel genes are highly associated with epilepsy. Mutation of SCN1A , the gene encoding the voltage gated sodium channel (VGSC) alpha subunit type 1 (Nav1.1), causes Dravet syndrome spectrum disorders. Mutations in SCN2A have been identified in patients with benign familial neonatal‐infantile epilepsy (BFNIE), generalised epilepsy with febrile seizures plus (GEFS+), and a small number of reported cases of other infantile‐onset severe intractable epilepsy. Here, we report three patients with infantile‐onset severe intractable epilepsy found to have de novo mutations in SCN2A . While a causal role for these mutations cannot be directly established, these findings contribute to growing evidence that mutation of SCN2A is associated with a range of epilepsy phenotypes including severe infantile‐onset epilepsy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom